Keri Donaldson
Penn State University College of Medicine, USA
Biography
Currently, Dr. Donaldson is the Director of the Clinical Processing Specimen Laboratory and the Director of the CLIA Laboratory in the Institute for Personalized Medicine at Penn State University where he is an assistant professor of biochemistry and molecular biology at the Penn State College of Medicine, and Milton S. Hershey Medical Center. Dr. Donaldson is also the founder and CEO of Prescient Medicine, where his work includes predictive disease modeling, preconditional drug response determination, and system failure point analysis and avoidance. He got his MD from Temple University School of Medicine and his MSCE from the University of Pennsylvania.
Abstract
Abstract : Validation of a Urine Assay for Polycystic Ovary Syndrome